Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Analysis of neuromuscular parameters in patients with multiple sclerosis and gait disorders.
Demyelinating disease: Neurodegeneration distinguishes MS from NMO.
Is it time to revise the classification of geographical distribution of multiple sclerosis?
Supernumerary phantom limbs in ICU patients with acute inflammatory demyelinating polyneuropathy.
Participant perceptions of a novel physiotherapy approach ("Blue Prescription") for increasing levels of physical activity in people with multiple sclerosis: a qualitative study following intervention.
Elastic modulus affects the growth and differentiation of neural stem cells.
Oligodendrocyte N-Methyl-D-aspartate Receptor Signaling: Insights into Its Functions.
Oligoclonal bands in multiple sclerosis patients: worse prognosis?
Robust Non-Local Multi-Atlas Segmentation of the Optic Nerve.
Measuring the Impact of Secondary Progressive Multiple Sclerosis (Spms) in the Ascend Trial: Equating the Msis-29, Msws-12, Abilhand-56 and Sf-36.
Considerations on the appropriateness of the John Cunningham virus antibody assay use in patients with rheumatoid arthritis.
Neutrophils Mediate Blood-Spinal Cord Barrier Disruption in Demyelinating Neuroinflammatory Diseases.
Bhlhe40 controls cytokine production by T cells and is essential for pathogenicity in autoimmune neuroinflammation.
Acid-sensing ion channels promote the inflammation and migration of cultured rat microglia.
Safety, Tolerability, and Efficacy of Oral Therapies for Relapsing-Remitting Multiple Sclerosis.
Efficacy and tolerability of different brands of intravenous immunoglobulin in the maintenance treatment of chronic immune mediated neuropathies.
Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances.
Glioblastoma following treatment with fingolimod for relapsing-remitting multiple sclerosis.
Detection of intrathecal immunoglobulin G synthesis by capillary isoelectric focusing immunoassay in oligoclonal band negative multiple sclerosis.
Cytometric profiling in various clinical forms of multiple sclerosis with respect to CD21+, CD32+, and CD35+ B and T cells.
Sphingosine 1-Phosphate Receptor Modulators in Multiple Sclerosis.
Revised diagnostic criteria of multiple sclerosis.
Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis.
Role of Tumor Necrosis Factor Superfamily in Neuroinflammation and Autoimmunity.
Blockade of Kv1.3 Potassium Channels Inhibits Differentiation and Granzyme B Secretion of Human CD8+ T Effector Memory Lymphocytes.

Pages